| Item | Description | Owner | Notes | Action |
|---|
| 1 | call to order and role call | JCA | | |
| 2 | Approval of minutes from 20160229 | JCA | | |
| 3 | Drug product Action Item follow up | JCA | - TMO to invite KCA to present the VA RxNorm project to the drug modeling group.
- Paul Amos to speak to Jo Goulding and Emma Melush about the use of mappings to the drug concepts being considered in the drug strength project.
- TMO to revise the proposal document after getting input from Paul Amos about Read Codes v.2.
- JCA said that TMO should collect input on the inactivation of concepts needing role from CMAG, then brief the MF. TMO should talk to IGR about how to do that.
- JCA instructed TMO to write up an inquiry to the MF and Content AG stating what the plan was, outlining benefits and detriments, and requesting information on how it would impact users.
| |
| 4 | Uses of slashes in FSN | JCA | Review discussion on editorial guidelines for use of "/" in FSN. Use+of+slashes+in+FSNs | |
| 5 | Continuation of Laterality proposal | JCA | Comments received from Content Managers Advisory Group | |
| 6 | Content tracker review | JCA | Content tracker dashboard | |
| 7 | Potential agenda topics for London meeting | JCA | We are meeting for a full day in London. Need substantive topics to move forward. | |
| 8 | May conference call date and time verification | JCA | JCA is traveling on Mar 23. Move call to May 30? | |
| 9 | Additional items | EAG | | |